| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pharmacyte Biotech, Inc. (PMCB) has 2 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. PMCB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 416.3K | $314.7K | - | |
| ? | 192.5K | $145.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Silverman Joshua62 | CEO And President | Buy | 100,000 | $0.80 | $80,476.00 | +9.6% | -17.9% | - | |
| Jan 7, 2026 | Schechter Jonathan72 | - | Buy | 60,000 | $0.80 | $48,232.00 | +13.1% | -17.9% | - |